Clinical Trial Update: Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating intraocular pressure reduction with the fixed combination of bimatoprost and timolol in glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• bimatoprost/timolol fixed combination (bimatoprost/timolol)

Snippet

Sponsor: Larissa University Hospital | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED